We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.51B
AUM Growth
+$540M
Cap. Flow
-$18.6M
Cap. Flow %
-0.34%
Top 10 Hldgs %
46.25%
Holding
691
New
31
Increased
112
Reduced
426
Closed
60

Top Buys

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$33.3M
2
BE icon
Bloom Energy
BE
+$30.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25M
4
SNDK
Sandisk
SNDK
+$23.5M
5
NBIS
Nebius Group N.V.
NBIS
+$22.4M

Top Sells

Rank Stock Value
1
BTI icon
British American Tobacco
BTI
+$36.2M
2
CLS icon
Celestica
CLS
+$21.9M
3
WMT icon
Walmart Inc
WMT
+$21.5M
4
UNH icon
UnitedHealth
UNH
+$20.7M
5
YUMC icon
Yum China
YUMC
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 48.98%
2 Communication Services 15.81%
3 Consumer Discretionary 13.07%
4 Healthcare 6.06%
5 Consumer Staples 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWST icon
426
Twist Bioscience
TWST
$5.69B
$36.6K ﹤0.01%
1,299
-221
-15% -$6.69K
KNSA icon
427
Kiniksa Pharmaceuticals
KNSA
$6.1B
$36.3K ﹤0.01%
935
-129
-12% -$4.19K
GPCR icon
428
Structure Therapeutics
GPCR
$3.52B
$35.8K ﹤0.01%
1,278
-247
-16% -$4.92K
MNKD icon
429
MannKind Corp
MNKD
$1.27B
$35.4K ﹤0.01%
6,601
-460
-7% -$2.02K
CURB
430
Curbline Properties
CURB
$3.52B
$35.3K ﹤0.01%
1,581
-89
-5% -$2.01K
ZLAB icon
431
Zai Lab
ZLAB
$2.06B
$34.9K ﹤0.01%
1,029
-307
-23% -$10.6K
BCRX icon
432
BioCryst Pharmaceuticals
BCRX
$2.35B
$34.3K ﹤0.01%
4,516
-787
-15% -$6.55K
VCEL icon
433
Vericel Corp
VCEL
$2.43B
$34.2K ﹤0.01%
1,086
-178
-14% -$6.39K
HRMY icon
434
Harmony Biosciences
HRMY
$2.08B
$34.1K ﹤0.01%
1,238
-222
-15% -$7.65K
ABCL icon
435
AbCellera Biologics
ABCL
$1.74B
$32.3K ﹤0.01%
6,429
-1,134
-15% -$5K
AVDL
436
DELISTED
Avadel Pharmaceuticals
AVDL
$31.9K ﹤0.01%
2,089
-378
-15% -$4.92K
JANX icon
437
Janux Therapeutics
JANX
$950M
$31.6K ﹤0.01%
1,293
-50
-4% -$1.22K
IMCR icon
438
Immunocore
IMCR
$1.72B
$31.3K ﹤0.01%
862
-152
-15% -$5.16K
AUPH icon
439
Aurinia Pharmaceuticals
AUPH
$1.93B
$31.3K ﹤0.01%
2,832
-834
-23% -$9.11K
NVCR icon
440
NovoCure
NVCR
$1.77B
$31.1K ﹤0.01%
2,405
-365
-13% -$4.88K
NVAX icon
441
Novavax
NVAX
$1.22B
$30.3K ﹤0.01%
3,494
-607
-15% -$4.72K
SHO icon
442
Sunstone Hotel Investors
SHO
$2.18B
$29.8K ﹤0.01%
3,181
-190
-6% -$1.75K
BRK.B icon
443
Berkshire Hathaway Class B
BRK.B
$1.1T
$29.2K ﹤0.01%
58
-104
-64% -$50.4K
LTC
444
LTC Properties
LTC
$2.06B
$29.1K ﹤0.01%
789
-29
-4% -$1.03K
TXG icon
445
10x Genomics
TXG
$6.28B
$28.8K ﹤0.01%
2,461
-278
-10% -$3.63K
LENZ
446
LENZ Therapeutics
LENZ
$181M
$28.6K ﹤0.01%
614
-90
-13% -$3.31K
ARDX icon
447
Ardelyx
ARDX
$1.25B
$28.6K ﹤0.01%
5,185
-879
-14% -$4.77K
SNDX icon
448
Syndax Pharmaceuticals
SNDX
$1.73B
$28.5K ﹤0.01%
1,853
-333
-15% -$4.36K
XERS icon
449
Xeris Biopharma Holdings
XERS
$1.45B
$28.3K ﹤0.01%
3,474
-343
-9% -$2.28K
STOK icon
450
Stoke Therapeutics
STOK
$1.87B
$27.7K ﹤0.01%
1,179
-176
-13% -$3.02K
16 17
18
19 20

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q3 2025 Portfolio in Review

As of Q3 2025, GF Fund Management held 691 positions worth $5.51B, up 11% from $4.97B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q3 2025 filing shows 31 new, 112 increased, 426 reduced and 60 closed positions. Its largest new stake was Bloom Energy: 648,856 shares worth $54.9M. The largest sale was British American Tobacco, an estimated $36.2M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 46% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q3 2025 buy was Bloom Energy: 648,856 shares worth $54.9M.
  • GF Fund Management added most to Lumentum in Q3 2025, an estimated $33.3M increase.
  • GF Fund Management's biggest Q3 2025 reduction was British American Tobacco, cutting an estimated $36.2M.
  • GF Fund Management fully exited Yum China in Q3 2025, selling an estimated $14.8M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.51B portfolio in Q3 2025.
  • GF Fund Management opened 31 new positions and closed 60 in Q3 2025.
  • GF Fund Management's portfolio value rose 11% quarter-over-quarter to $5.51B.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.